TP53 and neoplasm: Recently a subset of genes were identified to show significantly different expression in p53 wild-type (WT) cells relative to p53-null cells after BPDE exposure in human colon carcinoma cells (HCT116), and the loss of this tumour suppressor influenced the metabolic activation of BaP [39].